- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Leukocyte Common Antigen antibody, also known as CD45RA antibody, recognizes receptor-type tyrosine-protein phosphatase C encoded by the PTPRC gene. This transmembrane protein tyrosine phosphatase is broadly expressed on hematopoietic cells and is commonly referred to as Leukocyte Common Antigen or LCA in diagnostic pathology. The CD45RA isoform arises through alternative splicing of exons within the extracellular domain and is preferentially expressed on naive T lymphocytes and certain subsets of B cells. Leukocyte Common Antigen antibody directed against CD45RA enables specific identification of this functionally distinct leukocyte population rather than detecting all CD45 isoforms indiscriminately.
CD45 functions as a critical regulator of antigen receptor signaling in both T cells and B cells. Through its intracellular phosphatase domains, it modulates Src family kinases such as LCK and FYN, thereby influencing thresholds for lymphocyte activation, proliferation, and differentiation. CD45RA expression is typically associated with naive T cells, while memory T cells often shift toward alternative isoforms such as CD45RO. As a result, CD45RA detection is widely used to distinguish immune cell maturation states in research models of immune development, infection, and autoimmunity.
Receptor-type tyrosine-protein phosphatase C is localized to the plasma membrane and contains a large glycosylated extracellular region, a single-pass transmembrane segment, and tandem cytoplasmic phosphatase domains. Differential glycosylation and isoform variation contribute to multiple apparent molecular weight forms observed in SDS-PAGE analysis. The CD45RA isoform contains the exon A-encoded sequence within its extracellular region, which provides structural diversity without altering the conserved intracellular catalytic domains.
In clinical and translational research, CD45RA expression patterns assist in immunophenotypic classification of lymphoid populations. Altered CD45 isoform distribution has been described in leukemia and lymphoma subtypes, as well as in studies of immune reconstitution and transplantation biology. A recombinant monoclonal Leukocyte Common Antigen antibody targeting CD45RA provides consistent batch-to-batch performance due to defined sequence expression rather than hybridoma variability. This antibody targets CD45RA for research applications involving characterization of leukocyte subsets in normal and disease contexts.
1. Optimal dilution of the Leukocyte Common Antigen/CD45RA antibody should be determined by the researcher.
2. This Leukocyte Common Antigen/CD45RA antibody is recombinantly produced by expression in human HEK293 cells.
3. Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121oC in pH 7.8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37oC for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
A recombinant fragment (around amino acids 1-600) of human PTPRC protein (extracellular domain) was used as the immunogen for the Leukocyte Common Antigen/CD45RA antibody.
Leukocyte Common Antigen/CD45RA antibody with sodium azide - store at 2 to 8oC; antibody without sodium azide - store at -20 to -80oC.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.